| Abstrakt: |
Researchers at the All India Institute of Medical Sciences (AIIMS) have conducted a study on siRNA-based therapy, a promising class of molecules in molecular medicine. siRNA can be engineered to target specific genes linked to diseases, providing a focused and accurate method of modulating gene expression. The selectivity of siRNA allows for the customization of sequences to target different diseases, improving the accuracy of therapeutic interventions. However, the effective delivery of siRNA remains a challenge, and various delivery systems are being investigated to increase stability and cellular uptake. [Extracted from the article] |
